comparemela.com

Latest Breaking News On - Hematologic disease - Page 1 : comparemela.com

CT Poses Risk for Malignant Hematopathies Among Children

Data suggest that risk increases even with low radiation doses.

International-agency-for-research-on-cancer
International-agency
Toxicology
Toxicity
Poisoning
Toxins
Computed-tomography
It
Ct-scan
Hematologic-disorders
Hematologic-disease

A New Sickle Cell Cure Could Be A Game Changer For Many Black Americans

The FDA is beginning to review a new therapy for sickle cell, a disease that disproportionatley impacts Black Americans in the U.S..

United-states
Americans
Drug-administration
Black-americans
Health
Medical
Dharma
Gene-delivery
Biotechnology
Hematologic-disease
Gene-therapy

Glucocorticoid and glycolysis inhibitors cooperatively abrogate acute graft-versus-host disease

Glucocorticoid and glycolysis inhibitors cooperatively abrogate acute graft-versus-host disease
sciencex.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sciencex.com Daily Mail and Mail on Sunday newspapers.

China
Peking
Beijing
Qi-wen
Yuan-kong-peking-university-people-hospital
Xiao-jun-huang-peking-university-people-hospital
Science-china-life-sciences
University-institute-of-hematology
National-clinical-research-center
Science-china
Science-china-press
Yuan-kong

Glucocorticoid and glycolysis inhibitors cooperatively abrogate acute graft-versus-host disease

Glucocorticoid and glycolysis inhibitors cooperatively abrogate acute graft-versus-host disease
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Peking
Beijing
China
Yuan-kong-peking-university-people-hospital
Xiao-jun-huang-peking-university-people-hospital
National-clinical-research-center
University-institute-of-hematology
Yuan-kong
Peking-university-people
Peking-university-institute
Hematologic-disease

NHS England Treats First Sickle Cell Patients with 'Life-Changing' Drug

Around 5000 patients are likely to benefit from the drug over the next 3 years.

United-kingdom
Loury-mooruth
National-institute-for-health
Sickle-cell-society
Health-inequalities
Novartis
National-institute
Care-excellence
Managed-access-agreement
Sickle-cell-patients
Bola-owolabi
Sickle-cell-disease

vimarsana © 2020. All Rights Reserved.